Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LEXMA Technology is a private scientific computing and simulation company that develops the MOEBIUS multi-scale, multi-physics modeling platform. The company appears to serve multiple industries, including life sciences, where its software is positioned for drug discovery, microfluidics, and healthcare-device simulation rather than development of proprietary therapeutics. Publicly available information indicates that LEXMA combines computational science, engineering, and cloud or on-premises deployment capabilities to support digital prototyping and modeling workflows. In healthcare-related use cases, the company has highlighted applications in ventilators, diagnostics, PLGA droplet generation, and broader drug-discovery simulation. Based on available evidence, LEXMA is best characterized as a commercial health-adjacent technology company rather than a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LEXMA.